Found: 18
Select item for more details and to access through your institution.
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3492, doi. 10.1245/s10434-022-11413-7
- By:
- Publication type:
- Article
Effectiveness of Primary Care Interventions Using a Biopsychosocial Approach in Chronic Low Back Pain: A Systematic Review.
- Published in:
- Pain Practice, 2019, v. 19, n. 2, p. 224, doi. 10.1111/papr.12735
- By:
- Publication type:
- Article
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 3, p. 316, doi. 10.1111/j.1365-2141.2007.06661.x
- By:
- Publication type:
- Article
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
- Published in:
- 2000
- By:
- Publication type:
- case study
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Temozolomide as salvage treatment in primary brain lymphomas.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.
- Published in:
- British Journal of Cancer, 2004, v. 90, n. 2, p. 353, doi. 10.1038/sj.bjc.6601472
- By:
- Publication type:
- Article
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
- Published in:
- British Journal of Cancer, 2004, v. 90, n. 2, p. 283, doi. 10.1038/sj.bjc.6601488
- By:
- Publication type:
- Article
Second-line treatment for primary central nervous system lymphoma.
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 3/4, p. 530, doi. 10.1038/sj.bjc.6690083
- By:
- Publication type:
- Article
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 769, doi. 10.1007/s00280-009-0926-8
- By:
- Publication type:
- Article
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 673, doi. 10.1007/s00280-007-0653-y
- By:
- Publication type:
- Article
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 3, p. 361, doi. 10.1007/s00280-006-0277-7
- By:
- Publication type:
- Article
Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article